VieCure develops an AI platform to support personalized cancer treatment and patient management.
Founded in 2015 and based in Greenwood Village, Colorado, VieCure develops an AI platform for cancer care. It combines clinical data, genomic insights, and treatment protocols to support oncology providers in care decisions and workflow management. Its platform serves oncology practices, including more than 80 contracted cancer center locations across North America. In January 2026, VieCure raised USD 43 million co-led by Northpond Ventures and an individual investor, with Durable Capital Partners, Socium Ventures, and Sator Grove Holdings participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in